Douglas RS, Couch S, Wester ST, Fowler BT, et al. Efficacy and Safety of Teprotumumab in Thyroid Eye Disease Patients with Long Duration and Low Disease Activity. J Clin Endocrinol Metab 2023 Oct 31:dgad637. doi: 10.1210.
PMID: 37925673